Clinical usefulness and diagnostic value of percutaneous liver biopsy in patients with chronically elevated liver enzymes of non-viral origin;Klinischer nutzen und diagnostische bedeutung der leberbiopsie bei chronisch erhöhten leberwerten nicht viraler genese

Zeitschrift fur Gastroenterologie

Volumn 41, Issue 4, 2003, Pages 303-309

  Schwake, Lukas ^a   Muller U ^a   Theilmann, L ^b   Von Herbay, A ^a   Hofmann, W J ^a   Stremmel, W ^a   Kallinowski, B ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Medizinische Klinik II   (Germany)

Author keywords

Diagnostic value; Elevated liver enzymes; Liver biopsy

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY TRACT DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEPATITIS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; PERCUTANEOUS BIOPSY; SERODIAGNOSIS;

ADULT; AGED; ALANINE TRANSAMINASE; BIOPSY; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OBSERVER VARIATION; SENSITIVITY AND SPECIFICITY;

EID: 0037696401     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38644     Document Type: Article

References (34)

1. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993; 105: 1824-1832
2. Goldstein NS, Kodali VP, Gordon SC. Histologic spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type c hepatitis. Am J Clin Pathol 1995; 104: 567-573
3. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435
4. Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520
5. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699
6. Ludwig J. Histopathological diagnosis and terminology of chronic hepatitis. J Hepatol 1995; 23 (Suppl. 1): 49-53
7. Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Int Med 1989; 111: 473-478
8. Gaiani S, Gramantieri L, Venturoli N et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997; 27: 979-985
9. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500
10. Dienes HP, Drebber U, von Both I. Liver biopsy in hepatitis C. J Hepatol 1999; 31 (Suppl 1): 43-46
11. Piccinino F, Sagnelli E, Pasquale G et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165-173
12. Glaser J, Pausch J. The risk of liver biopsy. Z Gastroenterol 1995; 33: 673-676
13. Janes CH, Lindor KD. Outcome of patiens hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993; 118: 96-98
14. Lindor KD, Bru C, Jorgensen RA et al. The role of ultrasonography and automatic needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996; 23: 1079-1083
15. Chahal PS, Ready J. Hemothorax after percutaneous liver biopsy: an unusual complication. Am J Gastroenterol 2002; 97: 1068-1069
16. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol 1999; 5: 301-304
17. Leuschner U, Leuschner M, Strohm WD et al. Laparoskopie und Blindpunktion in der modernen Leberdiagnostik. Leber Magen Darm 1981; 11: 245-250
18. Hultcrantz R, Glaumann H, Lindberg G et al. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986; 21: 109-113
19. Friedman LS, Dienstag JL, Watkins E et al. Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Int Med 1987; 107: 137-144
20. Hay JE, Czaja AJ, Rakela J et al. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 1989; 9: 193-197
21. Giger A, Reichen J. Die Leberbiopsie beim ambulanten Patienten. Schweiz Med Wochenschr 1993; 123: 1474-1481
22. Caldwell SH, Oelsner DH, Iezzoni JC et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669
23. Daniel S, Ben-Menachem et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94: 3010-3014
24. Berasain C, Betes M, Panizo A et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 2000; 47: 429-435
25. Kundrotas LW, Clement DJ. Serum alanine aminotransferase (ALT) elevation in asymptomatic US air force basic trainee blood donors. Dig Dis Sci 1993; 38: 2145-2150
26. Piton A, Poynard T, Imbert-Bismut F et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology 1998; 27: 1213-1219
27. Pratt DS, Kaplan MM. Primary Care: Evaluation of abnormal liver-enzyme results in asymptomatic patients. NEJM 2000; 342: 1266-1271
28. Tsukada H, Wang PY, Kaneko T et al. Dietary carbohydrate intake plays an important role in preventing alcoholic fatty liver in the rat. J Hepatol 1998; 29: 715-724
29. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-723
30. Marchesini G, Brizi M, Bianchi G et al. Metformin in non-alcoholic steatohepatitis. Lancet 2001; 358: 893-894
31. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27-41
32. Dancygier H. 'Alcoholic' liver damage in nonalcoholics. Nonalcoholic steatohepatitis. Dtsch Med Wochenschr 1997; 122: 1183-1188
33. Feist D. 'Alcoholic' liver damage in non-alcoholics: nonalcoholic steatohepatitis. Dtsch Med Wochenschr 1998; 123: 237
34. Czaja AJ, Carpenter HA, Santrach PJ et al. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 1993; 104: 1755-1761